HomeKROS • NASDAQ
add
Keros Therapeutics Inc
Previous close
$14.03
Day range
$13.76 - $14.22
Year range
$9.12 - $72.37
Market cap
571.46M USD
Avg Volume
1.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 211.25M | 254,413.25% |
Operating expense | 10.50M | 1.83% |
Net income | 148.45M | 444.32% |
Net profit margin | 70.27 | 100.14% |
Earnings per share | 3.62 | 399.17% |
EBITDA | 152.38M | 416.11% |
Effective tax rate | 6.34% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 720.54M | 62.86% |
Total assets | 784.56M | 61.49% |
Total liabilities | 55.69M | 74.73% |
Total equity | 728.87M | — |
Shares outstanding | 40.62M | — |
Price to book | 0.78 | — |
Return on assets | 54.28% | — |
Return on capital | 56.83% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 148.45M | 444.32% |
Cash from operations | 161.17M | 461.69% |
Cash from investing | -565.00K | 40.27% |
Cash from financing | 4.00K | -100.00% |
Net change in cash | 160.61M | 44.31% |
Free cash flow | 105.47M | 418.26% |
About
Founded
2015
Headquarters
Website
Employees
163
